Sonim Technologies - SONM Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sonim Technologies in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" SONM shares.
View SONM analyst ratings or view top-rated stocks.

Sonim Technologies' stock was trading at $0.9218 on January 1st, 2022. Since then, SONM shares have decreased by 11.5% and is now trading at $0.8162.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 8th 2022.
View our SONM earnings forecast.

Sonim Technologies, Inc. (NASDAQ:SONM) issued its earnings results on Wednesday, November, 10th. The company reported ($1.31) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.70) by $0.61. The firm had revenue of $14.45 million for the quarter, compared to analyst estimates of $16.10 million. Sonim Technologies had a negative net margin of 65.77% and a negative trailing twelve-month return on equity of 264.64%.

Shares of Sonim Technologies reverse split on the morning of Thursday, September 16th 2021. The 1-10 reverse split was announced on Thursday, September 16th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, September 16th 2021. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

51 employees have rated Sonim Technologies Chief Executive Officer Bob Plaschke on Glassdoor.com. Bob Plaschke has an approval rating of 85% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Sonim Technologies investors own include TherapeuticsMD (TXMD), Acasti Pharma (ACST), Outlook Therapeutics (OTLK), Nabriva Therapeutics (NBRV), SCYNEXIS (SCYX), Allena Pharmaceuticals (ALNA), electroCore (ECOR), Heat Biologics (HTBX), Matinas BioPharma (MTNB) and NIO (NIO).

(SONM) raised $50 million in an initial public offering on Friday, May 10th 2019. The company issued 3,600,000 shares at $13.00-$15.00 per share. Oppenheimer and Lake Street served as the underwriters for the IPO and National Securities Corporation was co-manager.

Sonim Technologies trades on the NASDAQ under the ticker symbol "SONM."

Sonim Technologies' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Millennium Management LLC (0.53%). Insiders that own company stock include Ajp Holding Company, Llc, Brc Partners Opportunity Fund,, Hao Peter Liu, Jeffrey Wang, Maurice Hochschild, Nokomis Capital, LLC, Robert L Tirva, Robert L Tirva and Thomas Wiley Wilkinson.
View institutional ownership trends.

Shares of SONM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SONM stock can currently be purchased for approximately $0.82.

Sonim Technologies (NASDAQ:SONM) has a market capitalization of $15.73 million and generates $54.57 million in revenue each year. The company earns $-38,630,000.00 in net income (profit) each year or ($3.05) on an earnings per share basis.

Sonim Technologies' mailing address is 6836 Bee Cave Road Bldg. 1 S#279, Austin TX, 78746. The official website for the company is www.sonimtech.com. The company can be reached via phone at (650) 378-8100 or via email at sonm@gatewayir.com.